Patents Assigned to Vertex Pharmaceuticals (San Diego) LLC
-
Patent number: 8426201Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: September 28, 2009Date of Patent: April 23, 2013Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 8071318Abstract: Drug candidate screening methods are applied to discover compounds with activity against ion channel targets. The method may include modulating the transmembrane potential of host cells in a plurality of sample wells with a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: February 2, 2004Date of Patent: December 6, 2011Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7923537Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: May 31, 2006Date of Patent: April 12, 2011Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7767408Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: May 31, 2006Date of Patent: August 3, 2010Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7695922Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: May 30, 2006Date of Patent: April 13, 2010Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Publication number: 20100081163Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: ApplicationFiled: September 28, 2009Publication date: April 1, 2010Applicant: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7615357Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: May 31, 2006Date of Patent: November 10, 2009Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7615356Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: July 14, 2003Date of Patent: November 10, 2009Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7611850Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: May 31, 2006Date of Patent: November 3, 2009Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7399599Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: March 12, 2001Date of Patent: July 15, 2008Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7312043Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: March 12, 2001Date of Patent: December 25, 2007Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 7176016Abstract: Drug candidate screening methods are applied to discover compounds with activity against ion channel targets. The method may include modulating the transmembrane potential of host cells in a plurality of sample wells with a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.Type: GrantFiled: February 2, 2004Date of Patent: February 13, 2007Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 6969449Abstract: Plate and electrode assemblies include configurations allowing for relatively uniform electric field production. The electrodes may comprise strips of conductive material plated onto the bottom surface of sample wells or they may comprise plate electrodes extending down into the well. In some embodiments, the electric field strength varies by less than about 10% from a mean field intensity over at least about 20% of the surface area of the bottom surface of a sample well.Type: GrantFiled: March 12, 2001Date of Patent: November 29, 2005Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Michael P. Maher, Jesus E. Gonzalez, III
-
Patent number: 6855513Abstract: The invention provides methods for identifying a modulator of quorum sensing signaling in bacteria, and for identifying a quorum sensing controlled gene in bacteria. In addition, the invention provides quorum sensing controlled genetic loci in Pseudomas aeruginosa. Novel indicator strains and vectors for engineering the strains for use in the method of the invention are also provided.Type: GrantFiled: September 1, 2000Date of Patent: February 15, 2005Assignees: University of Iowa Research Foundation, Vertex Pharmaceuticals (San Diego) LLCInventors: Marvin Whiteley, Kimberly M. Lee, E. Peter Greenberg, Ute Muh
-
Patent number: 6825042Abstract: A microplate lid having a substantially flat, generally rectangular top with first and second pairs of opposite sides. A flange depends from the top of the first and second pairs of sides, the flange bearings at least one recess area along each side of the first pair of sides, the recessed area extended into the top.Type: GrantFiled: November 27, 2000Date of Patent: November 30, 2004Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Christopher B. Shumate, Peter J. Coassin
-
Patent number: 6780975Abstract: Engineered fluorescent proteins, nucleic acids encoding them and methods of use are provided.Type: GrantFiled: February 5, 2002Date of Patent: August 24, 2004Assignees: The Regents of the University of California, Vertex Pharmaceuticals (San Diego) LLC, State of Oregon Acting by and through the State Board of Higher Education on behalf of the University of OregonInventors: Roger Y. Tsien, S. James Remington, Andrew B. Cubitt, Roger Heim, Mats F. Ormö
-
Patent number: 6608671Abstract: The invention provides for a detector assembly, fiber assembly and screening system for optical measurements.Type: GrantFiled: July 17, 1998Date of Patent: August 19, 2003Assignee: Vertex Pharmaceuticals (San Diego) LLCInventors: Roger Y. Tsien, Peter J. Coassin, Andrew A. Pham, Alec Tate Harootunian, Minh Vuong
-
Patent number: 6514687Abstract: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods.Type: GrantFiled: December 10, 1999Date of Patent: February 4, 2003Assignee: Vertex Pharmaceuticals (San Diego), LLCInventors: Lewis R. Makings, Gregor Zlokarnik
-
Patent number: 6472218Abstract: Substances having useful pharmacological properties are identified by candidate screeners and screening methods. The substances may be incorporated into medicaments. The substances may have modulating activity with respect to pre-defined molecular targets.Type: GrantFiled: April 21, 1999Date of Patent: October 29, 2002Assignee: Vertex Pharmaceuticals (San Diego), LLCInventors: Chari Stylli, Samuel S. Beckey, Christopher Bentley Shumate, Peter J. Coassin
-
Patent number: 6468800Abstract: The present invention provides for systems and methods that utilize automated and integratable workstations for identifying chemicals having useful activity. The present invention is also directed to chemical entities and information (e.g., chemical or biological activities of chemicals) generated or discovered by operation of workstations of the present invention. The present invention includes automated workstations that are programmably controlled to minimize processing times at each workstation and that can be integrated to minimize the processing time of the liquid samples from the start to finish of the process.Type: GrantFiled: April 21, 1999Date of Patent: October 22, 2002Assignee: Vertex Pharmaceuticals (San Diego), LLCInventors: Chari Stylli, Samuel S. Beckey, Christopher Bentley Shumate, Peter J. Coassin